Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James J Harding

Showing results (101-110 of 138) with videos related to

Pageof 14
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 13, 2022
Comprehensive Molecular Characterization of Gallbladder Carcinoma and Potential Targets for InterventionNicolas A Giraldo, Esther Drill, Baby A Satravada, et al.
Cancer|August 20, 2021
Assessment of pegylated arginine deiminase and modified FOLFOX6 in patients with advanced hepatocellular carcinoma: Results of an international, single-arm, phase 2 studyJames J Harding, Tsai-Sheng Yang, Yen-Yang Chen, et al.
Medrxiv : the Preprint Server for Health Sciences|July 16, 2025
Delta-like ligand 3 expression and functional imaging in gastroenteropancreatic neuroendocrine neoplasmsRohit Thummalapalli, Salomon Tendler, Joanne F Chou, et al.
JCO Precision Oncology|February 23, 2024
Concordance in Oncogenic Alterations Between the Primary Tumor and Advanced Disease: Insights Into the Heterogeneity of Intrahepatic CholangiocarcinomaSarah M McIntyre, William A Preston, Henry Walch, et al.
JCO Precision Oncology|September 28, 2023
Targeted Molecular Profiling of Circulating Cell-Free DNA in Patients With Advanced Hepatocellular CarcinomaDarren Cowzer, Jessica B White, Joanne F Chou, et al.
The Oncologist|June 28, 2024
Clinicogenomic predictors of outcomes in patients with hepatocellular carcinoma treated with immunotherapyDarren Cowzer, Joanne F Chou, Henry Walch, et al.
JCO Precision Oncology|November 20, 2025
Delta-Like Ligand 3 Expression and Functional Imaging in Gastroenteropancreatic Neuroendocrine NeoplasmsRohit Thummalapalli, Salomon Tendler, Joanne F Chou, et al.
Journal of the National Cancer Institute|September 27, 2024
Long-term outcomes in patients with advanced intrahepatic cholangiocarcinoma treated with hepatic arterial infusion chemotherapyDarren Cowzer, Kevin Soares, Henry Walch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 26, 2026
Molecular and Clinical Determinants of Targeted Therapy Treatment in Biliary Tract CancerDarren Cowzer, Henry Walch, Pranita Atri, et al.
Future Oncology (London, England)|August 8, 2024
A plain language summary of the results from the phase 2b HERIZON-BTC-01 study of zanidatamab in participants with HER2-amplified biliary tract cancerJames J Harding, Jia Fan, Do-Youn Oh, et al.
Pageof 14

Showing results (101-110 of 138) with videos related to

Sort By:
Pageof 14
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 13, 2022
Comprehensive Molecular Characterization of Gallbladder Carcinoma and Potential Targets for InterventionNicolas A Giraldo, Esther Drill, Baby A Satravada, et al.
Cancer|August 20, 2021
Assessment of pegylated arginine deiminase and modified FOLFOX6 in patients with advanced hepatocellular carcinoma: Results of an international, single-arm, phase 2 studyJames J Harding, Tsai-Sheng Yang, Yen-Yang Chen, et al.
Medrxiv : the Preprint Server for Health Sciences|July 16, 2025
Delta-like ligand 3 expression and functional imaging in gastroenteropancreatic neuroendocrine neoplasmsRohit Thummalapalli, Salomon Tendler, Joanne F Chou, et al.
JCO Precision Oncology|February 23, 2024
Concordance in Oncogenic Alterations Between the Primary Tumor and Advanced Disease: Insights Into the Heterogeneity of Intrahepatic CholangiocarcinomaSarah M McIntyre, William A Preston, Henry Walch, et al.
JCO Precision Oncology|September 28, 2023
Targeted Molecular Profiling of Circulating Cell-Free DNA in Patients With Advanced Hepatocellular CarcinomaDarren Cowzer, Jessica B White, Joanne F Chou, et al.
The Oncologist|June 28, 2024
Clinicogenomic predictors of outcomes in patients with hepatocellular carcinoma treated with immunotherapyDarren Cowzer, Joanne F Chou, Henry Walch, et al.
JCO Precision Oncology|November 20, 2025
Delta-Like Ligand 3 Expression and Functional Imaging in Gastroenteropancreatic Neuroendocrine NeoplasmsRohit Thummalapalli, Salomon Tendler, Joanne F Chou, et al.
Journal of the National Cancer Institute|September 27, 2024
Long-term outcomes in patients with advanced intrahepatic cholangiocarcinoma treated with hepatic arterial infusion chemotherapyDarren Cowzer, Kevin Soares, Henry Walch, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 26, 2026
Molecular and Clinical Determinants of Targeted Therapy Treatment in Biliary Tract CancerDarren Cowzer, Henry Walch, Pranita Atri, et al.
Future Oncology (London, England)|August 8, 2024
A plain language summary of the results from the phase 2b HERIZON-BTC-01 study of zanidatamab in participants with HER2-amplified biliary tract cancerJames J Harding, Jia Fan, Do-Youn Oh, et al.
Pageof 14